Trial Details

Not Recruiting
Basic Information
Clinical ID c5119
Identifier EUCTR2011-000897-80-BE
Trial Title PHASE II RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF rhuMAb BETA7 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Ulcerative colitis MedDRA version: 14.0.Level: LLT.Classification code 10045365.Term: Ulcerative colitis.System Organ Class: 10017947 - Gastrointestinal disorders.;Therapeutic area: Diseases [C] - Digestive Syst
Interventions Product Name: rhuMAb Beta7Product Code: PRO145223 (RO5490261)Pharmaceutical Form: Solution for injectionINN or Proposed INN: n.a.Current Sponsor code: PRO145223 (RO5490261)Other descriptive name: rhuMAb Beta7Concentration unit:
Participant Information
Sponsor Genentech, Inc.
City NULL
Country/Region United States;Hungary;Czech Republic;Canada;Spain;Belgium;Australia;Israel;Germany;United Kingdom;New Zealand
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE2
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL